Impact of Surfactant's Availability on Newborns

NCT00005432 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-03-16

No results posted yet for this study

Summary

To identify what happened to specific groups of newborns after surfactant was introduced to the market. Were the same benefits with regard to morbidity, mortality, and resource use in evidence post treatment investigational new drug (IND)?

Conditions

  • Lung Diseases
  • Respiratory Distress Syndrome

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-05-31
Completion
1997-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005432 on ClinicalTrials.gov